Natural Evolution of H5N1 Hemagglutinin Amino Acid Sequence and Its Implication on Human Adaptation and Antigenicity
Exclusively Licensed
Invention type: Technology
/
Case number: #16072
The present invention provides, among other things, technologies and methodologies for detection, treatment, and/or prevention of influenza transmission and/or infection. The present invention also provides technologies for monitoring influenza HA variants with particular degrees of susceptibility to mutation for human adaptation.
Researchers
Rahul Raman
/
Nathan Stebbins
/
Kannan Tharakaraman
/
Karthik Viswanathan
/
Ram Sasisekharan
Departments: Department of Biological Engineering, School of Engineering
Technology Areas: Diagnostics: Assays / Therapeutics: Nucleic Acids, Proteins & Antibodies
-
human adaptation of h5 influenza
Japan | Granted | 6,518,597 -
human adaptation of h5 influenza
Russian Federation | Granted | 2,708,447 -
human adaptation of h5 influenza
Germany | Granted | 2,953,967 -
human adaptation of h5 influenza
France | Granted | 2,953,967 -
human adaptation of h5 influenza
United Kingdom | Granted | 2,953,967 -
human adaptation of h5 influenza
Hong Kong | Granted | 1,215,257 -
human adaptation of h5 influenza
Canada | Granted | 2,898,633 -
human adaptation of h5 influenza
Australia | Granted | 2,014,214,754 -
human adaptation of h5 influenza
India | Granted | 534,921 -
human adaptation of h5 influenza
Hong Kong | Granted | 1,218,923 -
human adaptation of h5 influenza
Brazil | Granted | 0 -
human adaptation of h5 influenza
Singapore | Granted | 11,201,505,744 -
human adaptation of h5 influenza
China | Granted | 105,263,954 -
human adaptation of h5 influenza
European Patent Convention | Granted | 2,953,967
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.